CLINICAL_TRIALS
trial_result
· 2010-04-27
Clinical Trial Update: The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months [Phase 3]
Summary
Phase 3 trial update reports safety findings for a new drug used for nine months in patients with Benign Prostatic Hyperplasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Watson Pharmaceuticals | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2010-04-27